BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 34745117)

  • 1. IL-40: A New B Cell-Associated Cytokine Up-Regulated in Rheumatoid Arthritis Decreases Following the Rituximab Therapy and Correlates With Disease Activity, Autoantibodies, and NETosis.
    Navrátilová A; Andrés Cerezo L; Hulejová H; Bečvář V; Tomčík M; Komarc M; Veigl D; Tegzová D; Závada J; Olejárová M; Pavelka K; Vencovský J; Šenolt L
    Front Immunol; 2021; 12():745523. PubMed ID: 34745117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synovial IL-21/TNF-producing CD4
    Lebre MC; Vieira PL; Tang MW; Aarrass S; Helder B; Newsom-Davis T; Tak PP; Screaton GR
    J Leukoc Biol; 2017 Mar; 101(3):775-783. PubMed ID: 27733582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-29 modulates proinflammatory cytokine production in synovial inflammation of rheumatoid arthritis.
    Wang F; Xu L; Feng X; Guo D; Tan W; Zhang M
    Arthritis Res Ther; 2012 Oct; 14(5):R228. PubMed ID: 23078630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Depletion of B lymphocytes in rheumatoid arthritis patients modifies IL-8-anti-IL-8 autoantibody network.
    Keren Z; Braun-Moscovici Y; Markovits D; Rozin A; Nahir M; Balbir-Gurman A; Melamed D
    Clin Immunol; 2009 Oct; 133(1):108-16. PubMed ID: 19632157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A regulatory effect of IL-21 on T follicular helper-like cell and B cell in rheumatoid arthritis.
    Liu R; Wu Q; Su D; Che N; Chen H; Geng L; Chen J; Chen W; Li X; Sun L
    Arthritis Res Ther; 2012 Nov; 14(6):R255. PubMed ID: 23176102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-20 is triggered by TLR ligands and associates with disease activity in patients with rheumatoid arthritis.
    Šenolt L; Prajzlerová K; Hulejová H; Šumová B; Filková M; Veigl D; Pavelka K; Vencovský J
    Cytokine; 2017 Sep; 97():187-192. PubMed ID: 28662439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated autoantibody content in rheumatoid arthritis synovia with lymphoid aggregates and the effect of rituximab.
    Rosengren S; Wei N; Kalunian KC; Zvaifler NJ; Kavanaugh A; Boyle DL
    Arthritis Res Ther; 2008; 10(5):R105. PubMed ID: 18761748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NETs are a source of citrullinated autoantigens and stimulate inflammatory responses in rheumatoid arthritis.
    Khandpur R; Carmona-Rivera C; Vivekanandan-Giri A; Gizinski A; Yalavarthi S; Knight JS; Friday S; Li S; Patel RM; Subramanian V; Thompson P; Chen P; Fox DA; Pennathur S; Kaplan MJ
    Sci Transl Med; 2013 Mar; 5(178):178ra40. PubMed ID: 23536012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New pro-inflammatory cytokine IL-40 is produced by activated neutrophils and plays a role in the early stages of seropositive rheumatoid arthritis.
    Navrátilová A; Bečvář V; Hulejová H; Tomčík M; Štolová L; Mann H; Růžičková O; Šléglová O; Závada J; Pavelka K; Vencovský J; Šenolt L; Andrés Cerezo L
    RMD Open; 2023 May; 9(2):. PubMed ID: 37208028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. B cell depletion with rituximab in patients with rheumatoid arthritis: Multiplex bead array reveals the kinetics of IgG and IgA antibodies to citrullinated antigens.
    Cambridge G; Leandro MJ; Lahey LJ; Fairhead T; Robinson WH; Sokolove J
    J Autoimmun; 2016 Jun; 70():22-30. PubMed ID: 27055777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synovial fluid levels of anti-cyclic citrullinated peptide antibodies and IgA rheumatoid factor in rheumatoid arthritis, psoriatic arthritis, and osteoarthritis.
    Caspi D; Anouk M; Golan I; Paran D; Kaufman I; Wigler I; Levartovsky D; Litinsky I; Elkayam O
    Arthritis Rheum; 2006 Feb; 55(1):53-6. PubMed ID: 16463412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. B-cell subsets in the joint compartments of seropositive and seronegative rheumatoid arthritis (RA) and No-RA arthritides express memory markers and ZAP70 and characterize the aggregate pattern irrespectively of the autoantibody status.
    Michelutti A; Gremese E; Morassi F; Petricca L; Arena V; Tolusso B; Alivernini S; Peluso G; Bosello SL; Ferraccioli G
    Mol Med; 2011; 17(9-10):901-9. PubMed ID: 21607290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced neutrophil extracellular trap generation in rheumatoid arthritis: analysis of underlying signal transduction pathways and potential diagnostic utility.
    Sur Chowdhury C; Giaglis S; Walker UA; Buser A; Hahn S; Hasler P
    Arthritis Res Ther; 2014 Jun; 16(3):R122. PubMed ID: 24928093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calgizzarin (S100A11): a novel inflammatory mediator associated with disease activity of rheumatoid arthritis.
    Andrés Cerezo L; Šumová B; Prajzlerová K; Veigl D; Damgaard D; Nielsen CH; Pavelka K; Vencovský J; Šenolt L
    Arthritis Res Ther; 2017 Apr; 19(1):79. PubMed ID: 28446208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Etanercept reduces the serum levels of interleukin-23 and macrophage inflammatory protein-3 alpha in patients with rheumatoid arthritis.
    Kageyama Y; Ichikawa T; Nagafusa T; Torikai E; Shimazu M; Nagano A
    Rheumatol Int; 2007 Dec; 28(2):137-43. PubMed ID: 17619881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of interleukin-1 beta, tumor necrosis factor alpha, interleukins-6, -10 and -4, and metalloproteases by freshly isolated mononuclear cells from early never-treated and non-acute treated rheumatoid arthritis patients.
    Vázquez-Del Mercado M; Delgado-Rizo V; Muñoz-Valle JF; Orozco-Alcalá J; Volk HD; Armendáriz-Borunda J
    Clin Exp Rheumatol; 1999; 17(5):575-83. PubMed ID: 10544841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased levels of interleukin 34 in serum and synovial fluid are associated with rheumatoid factor and anticyclic citrullinated peptide antibody titers in patients with rheumatoid arthritis.
    Moon SJ; Hong YS; Ju JH; Kwok SK; Park SH; Min JK
    J Rheumatol; 2013 Nov; 40(11):1842-9. PubMed ID: 23996288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synoviocytes-derived Interleukin 35 Potentiates B Cell Response in Patients with Osteoarthritis and Rheumatoid Arthritis.
    Kam NW; Liu D; Cai Z; Mak WY; Wong CK; Chiu KH; Wong KY; Tsang WL; Tam LS
    J Rheumatol; 2018 Apr; 45(4):563-573. PubMed ID: 29247146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The TNF superfamily member LIGHT contributes to survival and activation of synovial fibroblasts in rheumatoid arthritis.
    Pierer M; Brentano F; Rethage J; Wagner U; Hantzschel H; Gay RE; Gay S; Kyburz D
    Rheumatology (Oxford); 2007 Jul; 46(7):1063-70. PubMed ID: 17426140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The interleukin-20 receptor axis in early rheumatoid arthritis: novel links between disease-associated autoantibodies and radiographic progression.
    Kragstrup TW; Greisen SR; Nielsen MA; Rhodes C; Stengaard-Pedersen K; Hetland ML; Hørslev-Petersen K; Junker P; Østergaard M; Hvid M; Vorup-Jensen T; Robinson WH; Sokolove J; Deleuran B
    Arthritis Res Ther; 2016 Mar; 18():61. PubMed ID: 26968800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.